Total planned funding: $283,548,935
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
South Africa | $42,928,781 |
Mozambique | $35,844,399 |
Asia Regional Program | $35,475,616 |
Zambia | $33,856,710 |
Tanzania | $17,959,411 |
Nigeria | $15,559,065 |
West Africa Region | $13,460,980 |
Burundi | $10,981,534 |
Zimbabwe | $9,054,888 |
Vietnam | $8,071,117 |
Dominican Republic | $7,551,779 |
Ethiopia | $7,480,898 |
enumerations.Philippines | $6,341,584 |
Cambodia | $4,700,000 |
Malawi | $4,388,600 |
Kenya | $4,176,903 |
South Sudan | $3,430,000 |
Lesotho | $3,392,229 |
Indonesia | $3,380,435 |
Rwanda | $2,495,000 |
Democratic Republic of the Congo | $2,290,015 |
Botswana | $1,966,634 |
Eswatini | $1,960,500 |
Côte d'Ivoire | $1,571,882 |
Ghana | $1,290,000 |
India | $1,000,000 |
China | $850,000 |
Haiti | $827,217 |
Western Hemisphere Region | $709,018 |
Uganda | $353,740 |
Thailand | $200,000 |
Organizational Types
NGO | $283,548,935 |
Program Areas
Prevention | $83,398,763 |
Care | $74,778,959 |
Treatment | $65,129,345 |
Testing | $37,291,224 |
Governance and Systems | $22,950,644 |
Budget Codes
HTXS: Treatment: Adult Treatment | $55,592,104 |
HVOP: Sexual Prevention: Other Sexual Prevention | $40,036,077 |
HKID: Care: Orphans and Vulnerable Children | $38,784,539 |
HVCT: Testing: HIV Testing and Counseling | $37,291,224 |
HBHC: Care: Adult Care and Support | $25,819,144 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,550,673 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $15,380,881 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,107,183 |
HVSI: Strategic Information | $9,769,399 |
OHSS: Health Systems Strengthening | $7,966,629 |
HVTB: Care: TB/HIV | $5,729,681 |
HLAB: Laboratory Infrastructure | $5,214,616 |
HTXD: Treatment: ARV Drugs | $5,082,114 |
PDTX: Treatment: Pediatric Treatment | $4,455,127 |
PDCS: Care: Pediatric Care and Support | $4,445,595 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,228,949 |
HMIN: Biomedical Prevention: Injection Safety | $95,000 |